The National Institutes of Health (NIH) has posted a grant opportunity titled "Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)". This grant aims to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of diversity and re-entry supplements supported by the CTSA Program to conduct research as they complete the transition to fully independent academic translational scientists. The grant will support various clinical and translational science research projects, including pilot and feasibility studies, secondary data analysis, small self-contained research projects, development of research methodology, and development of new research technology. The research projects proposed in the grant application may or may not include patient-oriented research. The R03 grant is intended to support research projects that can be carried out in a short period of time with limited resources and provide preliminary data to support the submission of a subsequent R01 or equivalent application. The grant has a maximum award ceiling of $50,000. The deadline for application submission is October 19, 2026. For more information and to apply, visit the following link: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.